Evidence map›Paper›PMID 24086164›Full record

ArticlePLoS genetics2013

Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids.

Wenyan Jiang, Inbal Maniv, Fawaz Arain, Yaying Wang, Bruce R Levin, Luciano A Marraffini

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 247 citations in OpenAlex.

  1. Bacterial immune systems.Antonie van Leeuwenhoek · 2026
    Review
  2. Article
  3. Complete genome sequences ofMicrobiology resource announcements · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Phage susceptibility to a minimal, modular synthetic CRISPR-Cas system inPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Wenyan JiangLaboratory of Bacteriology, The Rockefeller University, New York, New York, United States of America.
Inbal Maniv
Fawaz Arain
Yaying Wang
Bruce R Levin
Luciano A Marraffini
Emory University · USRockefeller University · US

Funding

Theoretical and experimental strudy of the population and evolutionary dynamics oR01GM091875 · NIGMS · EMORY UNIVERSITY · PI LEVIN, BRUCE RICHARD · 2009 to 2017
$2.5M
Using CRISPR immunity to prevent the spread of virulence traits among pathogensDP2AI104556 · NIAID · ROCKEFELLER UNIVERSITY · PI MARRAFFINI, LUCIANO A · 2012 to 2012
$2.5M
NIAID NIH HHS 1DP2AI104556-01NIAID NIH HHS DP2 AI104556NIGMS NIH HHS GM 091875NIGMS NIH HHS R01 GM091875
6 · The paper itself

Abstract

The immune systems that protect organisms from infectious agents invariably have a cost for the host. In bacteria and archaea CRISPR-Cas loci can serve as adaptive immune systems that protect these microbes from infectiously transmitted DNAs. When those DNAs are borne by lytic viruses (phages), this protection can provide a considerable advantage. CRISPR-Cas immunity can also prevent cells from acquiring plasmids and free DNA bearing genes that increase their fitness. Here, we use a combination of experiments and mathematical-computer simulation models to explore this downside of CRISPR-Cas immunity and its implications for the maintenance of CRISPR-Cas loci in microbial populations. We analyzed the conjugational transfer of the staphylococcal plasmid pG0400 into Staphylococcus epidermidis RP62a recipients that bear a CRISPR-Cas locus targeting this plasmid. Contrary to what is anticipated for lytic phages, which evade CRISPR by mutations in the target region, the evasion of CRISPR immunity by plasmids occurs at the level of the host through loss of functional CRISPR-Cas immunity. The results of our experiments and models indicate that more than 10(-4) of the cells in CRISPR-Cas positive populations are defective or deleted for the CRISPR-Cas region and thereby able to receive and carry the plasmid. Most intriguingly, the loss of CRISPR function even by large deletions can have little or no fitness cost in vitro. These theoretical and experimental results can account for the considerable variation in the existence, number and function of CRISPR-Cas loci within and between bacterial species. We postulate that as a consequence of the opposing positive and negative selection for immunity, CRISPR-Cas systems are in a continuous state of flux. They are lost when they bear immunity to laterally transferred beneficial genes, re-acquired by horizontal gene transfer, and ascend in environments where phage are a major source of mortality.

Indexed as

Evolution, MolecularGenetic FitnessBacteriophagesClustered Regularly Interspaced Short Palindromic RepeatsGene Transfer, HorizontalHost-Parasite InteractionsImmunityPlasmidsSequence DeletionStaphylococcus epidermidis

Identifiers

PMID24086164
PMCPMC3784566
OpenAlexW2080392677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.